These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9825817)
1. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Jain AB; Yee LD; Nalesnik MA; Youk A; Marsh G; Reyes J; Zak M; Rakela J; Irish W; Fung JJ Transplantation; 1998 Nov; 66(9):1193-200. PubMed ID: 9825817 [TBL] [Abstract][Full Text] [Related]
2. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102 [TBL] [Abstract][Full Text] [Related]
3. De novo malignancies after liver transplantation: a major cause of late death. Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783 [TBL] [Abstract][Full Text] [Related]
5. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349 [TBL] [Abstract][Full Text] [Related]
6. De novo tumors after liver transplantation: a single-institution experience. Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575 [TBL] [Abstract][Full Text] [Related]
7. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490 [TBL] [Abstract][Full Text] [Related]
8. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients. Rademacher S; Seehofer D; Eurich D; Schoening W; Neuhaus R; Oellinger R; Denecke T; Pascher A; Schott E; Sinn M; Neuhaus P; Pratschke J Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598 [TBL] [Abstract][Full Text] [Related]
9. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age. Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population. Kellerman L; Neugut A; Burke B; Mancini D Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521 [TBL] [Abstract][Full Text] [Related]
11. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Yao FY; Gautam M; Palese C; Rebres R; Terrault N; Roberts JP; Peters MG Clin Transplant; 2006; 20(5):617-23. PubMed ID: 16968488 [TBL] [Abstract][Full Text] [Related]
12. Burden of de novo malignancy in the liver transplant recipient. Chandok N; Watt KD Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956 [TBL] [Abstract][Full Text] [Related]
14. Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Jain AB; Kashyap R; Rakela J; Starzl TE; Fung JJ Liver Transpl Surg; 1999 Mar; 5(2):144-50. PubMed ID: 10071354 [TBL] [Abstract][Full Text] [Related]
15. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037 [TBL] [Abstract][Full Text] [Related]
16. Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879 [TBL] [Abstract][Full Text] [Related]
17. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation. Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297 [TBL] [Abstract][Full Text] [Related]
18. Non-lymphoid cancer after liver transplantation. Frezza EE; Fung JJ; van Thiel DH Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620 [TBL] [Abstract][Full Text] [Related]
19. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091 [TBL] [Abstract][Full Text] [Related]
20. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]